The latest price target for Camp4 Therapeutics (NASDAQ:CAMP) was reported by William Blair on November 5, 2024. The analyst firm set a price target for $0.00 expecting CAMP to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Camp4 Therapeutics (NASDAQ:CAMP) was provided by William Blair, and Camp4 Therapeutics initiated their outperform rating.

The last upgrade for Camp4 Therapeutics Corp happened on August 16, 2022 when Craig-Hallum raised their price target to $10. Craig-Hallum previously had a hold for Camp4 Therapeutics Corp.

The last downgrade for Camp4 Therapeutics Corp happened on October 6, 2023 when Craig-Hallum changed their price target from N/A to $0.5 for Camp4 Therapeutics Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Camp4 Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Camp4 Therapeutics was filed on November 5, 2024 so you should expect the next rating to be made available sometime around November 5, 2025.

While ratings are subjective and will change, the latest Camp4 Therapeutics (CAMP) rating was a initiated with a price target of $0.00 to $0.00. The current price Camp4 Therapeutics (CAMP) is trading at is $5.82, which is out of the analyst’s predicted range.